Traws Pharma, Inc. (TRAW)
Traws Pharma, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Traws Pharma, Inc. (TRAW) is a Biotechnology company based in US with a market capitalization of $4.5M. Revenue grew 1134.5% year-over-year and free cash flow was negative at -$20.8M. This page tracks TRAW's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 6 employees · IPO Jul 25, 2013
Valuation
Valuation & price
$1.88as of May 17, 2026· -39.9% vs 52w high
1.7
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$4.5M
Market cap
1134.5%
Revenue growth (YoY)
100.0%
Gross margin
-$20.8M
Free cash flow (USD)
-$3.8M
Net debt
Net cash position
429.9%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
1
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.53)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 10, 2026Filing
Stock Offering Announcement
- 8-K eventJul 9, 2026Filing
Annual Meeting Results
- FinancingJul 1, 2026Filing
Securities Registration
- 8-K eventJun 22, 2026Filing
Regulatory Submission Update
- 8-K eventJun 12, 2026Filing
Regulatory Update
- 8-K eventMay 27, 2026Filing
Antiviral Program Announcement
- 8-K eventMay 26, 2026Filing
Share Offering
- 8-K eventMay 15, 2026Filing
Q1 2026 Financial Results
- Quarterly reportMay 15, 2026Filing
10-Q Filed
- FinancingMay 8, 2026Filing
Securities Registration
Questions
Frequently asked questions
What is Traws Pharma, Inc.'s market cap?
Traws Pharma, Inc. (TRAW) has a market capitalization of $4.5M.
What is TRAW's P/E ratio?
TRAW trades at a price-to-earnings ratio of 1.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
When did Traws Pharma, Inc. last report earnings?
TRAW last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying TRAW stock?
Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Traws Pharma, Inc. in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.